Ajanta Pharma Ltd.

Financial

	Ajanta Pharma	Sanofi India	Fortis Healthcare
Operational Metrics
Pharmaceutical Sector
Number of ANDA's Filed in USA	76.0 .	n/a	n/a
Number of ANDA's Approved By USFDA	54.0 .	n/a	n/a
Domestic Sales Growth - YoY	15.6 %	-1.2 %	n/a
R&D as a % of Total Sales	5.0 %	0.0	n/a
Financials
5 yr Average ROE	19.25 %	43.25 %	2.33 %
5yr average Equity Multiplier	1.34	3.33	1.73
5yr Average Asset Turnover Ratio	0.75	0.57	0.44
5yr Avg Net Profit Margin	19.31 %	22.99 %	2.18 %
Price to Book	7.96	18.78	4.4
P/E	37.67	31.62	60.61
5yr Avg Cash Conversion Cycle	19.66 Days	11.11 Days	-133.71 Days
Inventory Days	74.91 Days	48.47 Days	6.17 Days
Days Receivable	99.85 Days	13.83 Days	31.7 Days
Days Payable	219.9 Days	55.71 Days	220.67 Days
5yr Average Interest Coverage Ratio	165.94	1007.93	3.83
5yr Avg ROCE	24.04 %	29.56 %	4.56 %
5yr Avg Operating Profit Margin	29.77 %	28.62 %	14.05 %
5 yr average Debt to Equity	0.01	0.0	0.19
5yr CAGR Net Profit	8.73 %	41.96 %	n/a
5yr Average Return on Assets	14.36 %	13.01 %	1.32 %
Shareholdings
Promoter Holding	66.21 %	60.4 %	31.17 %
Share Pledged by Promoters	12.26 %	0.0	0.0
Change in Promoter Holding (3 Yrs)	-4.13 %	0.0	0.0
Change in Mutual Fund Holding (3 Yrs)	5.23 %	1.86 %	14.26 %

Business

	Ajanta Pharma	Sanofi India	Fortis Healthcare
Product Wise Break-Up	Product Wise Break-Up Pharmaceutical 100.0 Pharmaceuticals 0 Out-Patient Services 0 In-Patient Services 0	Product Wise Break-Up In-Patient Services 0 Pharmaceutical 100.0 Pharmaceutical 0 Out-Patient Services 0	Product Wise Break-Up In-Patient Services 85.57 Pharmaceuticals 0 Pharmaceutical 0 Out-Patient Services 13.51 Others 0.92
Segment Break-Up	Segment Break-Up Diagnostics 0 Healthcare 0 Others 100	-	Segment Break-Up Healthcare 80.78 Diagnostic Services 19.22
Therapeutic Area Wise Break-Up - Domestic	Therapeutic Area Wise Break-Up - Domestic RESPIRATORY 0 DERMA 0 ANTI-INFECTIVES 0 GASTRO INTESTINAL 0 NEURO/CNS 0 PAIN/ANALGES 0 CARDIAC 0 ANTI DIABETIC 0 VMN 0 Orthopedics 0 Renal 0 Neuro & Spine 0 Gastro 0 Oncology 0 Pulmonology 0 Gynecology 0 Cardiac 0 Others 100	Therapeutic Area Wise Break-Up - Domestic Gynecology 0 Pain Management 7.15 Orthopedics 0 Neuro & Spine 0 Gastro Intestinal 10.56 Anti-Infective 5.72 Central Nervous System (CNS) 6.86 VMN 0 Oncology 0 Renal 0 Anti - Diabetes 38.81 Pulmonology 0 Cardiac Science 17.42 Cardiac 0 Gastro 0 Respiratory Systems 13.48 DERMA 0	Therapeutic Area Wise Break-Up - Domestic Gynecology 3.7 PAIN/ANALGES 0 Orthopaedics 8.5 Central Nervous System (CNS) 8.7 GASTRO INTESTINAL 0 ANTI-INFECTIVES 0 NEURO/CNS 0 VMN 0 Oncology 14.2 Renal 7.4 ANTI DIABETIC 0 Pulmonology 3.1 CARDIAC 0 Cardiac Science 17.6 Gastro Intestinal 5.1 RESPIRATORY 0 DERMA 0 Others 31.7
Location Wise Break-Up	Location Wise Break-Up India 27.87 Asia Pacific 26.43 USA 22.81 Africa 21.81 Singapore 0 Rest of the World 0 South India 0 East India 0 West India 0 North India 0 Others 1.08	Location Wise Break-Up East India 0 South India 0 Asia Pacific 0 West India 0 North India 0 India 81.47 Rest of the World 0 USA 0 Singapore 17.88 Africa 0 Others 0.65	Location Wise Break-Up East India 14.0 South India 28.0 Asia Pacific 0 West India 21.0 North India 34.0 India 0 Rest of the World 3.0 USA 0 Singapore 0 Africa 0
Asset Break-Up	Asset Break-Up India 99.23 USA 0.44 Asia Pacific 0.23 Africa 0.09 Others 0.01	-	Asset Break-Up USA 0 Asia Pacific 0 Africa 0 India 98.91 Others 1.09

Ajanta Pharma Ltd.

SIGN UP FOR FREE